Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice

scientific article published on January 1, 1992

Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0264-410X(92)90027-H
P698PubMed publication ID1539464

P2093author name stringB. Meignier
F. Vaux-Peretz
J. M. Chapsal
Vaux-Peretz F
P433issue2
P407language of work or nameEnglishQ1860
P921main subjecthemagglutinin-neuraminidaseQ12902725
P304page(s)113-118
P577publication date1992-01-01
P1433published inVaccineQ7907941
P1476titleComparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice
P478volume10

Reverse relations

cites work (P2860)
Q36500189An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice
Q49820279Characterization of Cotton Rat (Sigmodon hispidus) Eosinophils, Including Their Response to Respiratory Syncytial Virus Infection
Q37197103Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology
Q33870528Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.
Q36362647Distinct types of lung disease caused by functional subsets of antiviral T cells
Q36626174Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.
Q45723621Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate
Q37871964Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue
Q40951360Immunopathological mechanisms in respiratory syncytial virus disease
Q40076730Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus
Q83400970Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV
Q36687435Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells
Q35070176Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease
Q35859950Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern
Q36483809Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection
Q45709995The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B.
Q41511965The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies
Q45353912The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease

Search more.